Update on Burkitt Lymphoma

被引：54

作者：

Dunleavy, Kieron ^{[1
]}

Little, Richard F. ^{[2
]}

Wilson, Wyndham H. ^{[1
]}

机构：

[1] NCI, Lymphoid Malignancies Branch, Ctr Canc Res, Bethesda, MD 20892 USA

[2] NCI, HIV & Stem Cell Therapeut, CTEP, Bethesda, MD 20892 USA

来源：

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2016年 / 30卷 / 06期

关键词：

Burkitt lymphoma; MYC; TCF3; CCND3; ID3; Risk-adapted; Endemic; Sporadic; PROMOTES GENOMIC INSTABILITY; MODIFIED CODOX-M/IVAC; NON-HODGKINS-LYMPHOMA; DOSE-ADJUSTED EPOCH; B-CELL LYMPHOMA; ADULT BURKITT; CHEMOTHERAPY; RITUXIMAB; THERAPY; APOPTOSIS;

D O I：

10.1016/j.hoc.2016.07.009

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Because of its rarity and high curability, progress in advancing therapeutics in Burkitt lymphoma (BL) has been difficult. Over recent years, several new mutations that cooperate with MYC have been identified, and this has paved the way for testing novel agents in the disease. One of the challenges of most standard approaches typically used is severe treatment related toxicity that often leads to discontinuation of therapy. To that point, there has been recent success developing intermediate intensity approaches that are well tolerated in all patient groups and maintain high cure rates in a multicenter setting.

引用

页码：1333 / +

页数：12

共 41 条

[11]

Heslop Helen E, 2005, Hematology Am Soc Hematol Educ Program, P260

[12] Improved outcome of adult Burkitt lymphoma/leukemia with rituximab and chemotherapy: report of a large prospective multicenter trial [J].

Hoelzer, Dieter ;

Walewski, Jan ;

Doehner, Hartmut ;

Viardot, Andreas ;

Hiddemann, Wolfgang ;

Spiekermann, Karsten ;

Serve, Hubert ;

Duehrsen, Ulrich ;

Huettmann, Andreas ;

Thiel, Eckhard ;

Dengler, Jolanta ;

Kneba, Michael ;

Schaich, Markus ;

Schmidt-Wolf, Ingo G. H. ;

Beck, Joachim ;

Hertenstein, Bernd ;

Reichle, Albrecht ;

Domanska-Czyz, Katarzyna ;

Fietkau, Rainer ;

Horst, Heinz-August ;

Rieder, Harald ;

Schwartz, Stefan ;

Burmeister, Thomas ;

Goekbuget, Nicola .

BLOOD, 2014, 124 (26) :3870-3879

[13] A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling [J].

Hummel, Michael ;

Bentink, Stefan ;

Berger, Hilmar ;

Klapper, Wolfram ;

Wessendorf, Swen ;

Barth, Thomas F. E. ;

Bernd, Heinz-Wolfram ;

Cogliatti, Sergio B. ;

Dierlamm, Judith ;

Feller, Alfred C. ;

Hansmann, Martin-Leo ;

Haralambieva, Eugenia ;

Harder, Lana ;

Hasenclever, Dirk ;

Kuehn, Michael ;

Lenze, Dido ;

Lichter, Peter ;

Ignacio Martin-Subero, Jose ;

Moeller, Peter ;

Mueller-Hermelink, Hans-Konrad ;

Ott, German ;

Parwaresch, Reza M. ;

Pott, Christiane ;

Rosenwald, Andreas ;

Rosolowski, Maciej ;

Schwaenen, Carsten ;

Stuerzenhofecker, Benjamin ;

Szczepanowski, Monika ;

Trautmann, Heiko ;

Wacker, Hans-Heinrich ;

Spang, Rainer ;

Loeffler, Markus ;

Truemper, Lorenz ;

Stein, Harald ;

Siebert, Reiner .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (23) :2419-2430

[14] SIRT4 Protein Suppresses Tumor Formation in Genetic Models of Myc-induced B Cell Lymphoma [J].

Jeong, Seung Min ;

Lee, Annie ;

Lee, Jaewon ;

Haigis, Marcia C. .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (07) :4135-4144

[15] Epstein-Barr virus promotes genomic instability in Burkitt's lymphoma [J].

Kamranvar, S. A. ;

Gruhne, B. ;

Szeles, A. ;

Masucci, M. G. .

ONCOGENE, 2007, 26 (35) :5115-5123

[16]

Kelly Gemma L, 2007, Hematology Am Soc Hematol Educ Program, P277

[17] Three restricted forms of Epstein-Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cells [J].

Kelly, Gemma L. ;

Milner, Anne E. ;

Baldwin, Gouri S. ;

Bell, Andrew I. ;

Rickinson, Alan B. .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (40) :14935-14940

[18] Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma and Indolent B-Cell Malignancies Can Be Effectively Treated With Autologous T Cells Expressing an Anti-CD19 Chimeric Antigen Receptor [J].

Kochenderfer, James N. ;

Dudley, Mark E. ;

Kassim, Sadik H. ;

Somerville, Robert P. T. ;

Carpenter, Robert O. ;

Stetler-Stevenson, Maryalice ;

Yang, James C. ;

Phan, Giao Q. ;

Hughes, Marybeth S. ;

Sherry, Richard M. ;

Raffeld, Mark ;

Feldman, Steven ;

Lu, Lily ;

Li, Yong F. ;

Ngo, Lien T. ;

Goy, Andre ;

Feldman, Tatyana ;

Spaner, David E. ;

Wang, Michael L. ;

Chen, Clara C. ;

Kranick, Sarah M. ;

Nath, Avindra ;

Nathan, Debbie-Ann N. ;

Morton, Kathleen E. ;

Toomey, Mary Ann ;

Rosenberg, Steven A. .

JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (06) :540-U31

[19] Epstein-Barr virus contributes to the malignant phenotype and to apoptosis resistance in Burkitt's lymphoma cell line Akata [J].

Komano, J ;

Sugiura, M ;

Takada, K .

JOURNAL OF VIROLOGY, 1998, 72 (11) :9150-9156

[20] The different epidemiologic subtypes of Burkitt lymphoma share a homogenous micro RNA profile distinct from diffuse large B-cell lymphoma [J].

Lenze, D. ;

Leoncini, L. ;

Hummel, M. ;

Volinia, S. ;

Liu, C. G. ;

Amato, T. ;

De Falco, G. ;

Githanga, J. ;

Horn, H. ;

Nyagol, J. ;

Ott, G. ;

Palatini, J. ;

Pfreundschuh, M. ;

Rogena, E. ;

Rosenwald, A. ;

Siebert, R. ;

Croce, C. M. ;

Stein, H. .

LEUKEMIA, 2011, 25 (12) :1869-1876

← 1 2 3 4 5 →